Zurück
Vor
E-Plate CardioECR 48
 
 

E-Plate CardioECR 48

Packungsgröße

Hersteller ACEA Biosciences Inc.

Artikel-Nr.: 2801192

xCELLigence Systems

Brochures & Applications

Preis auf Anfrage

 
 
 

Die mit einem * markierten Felder sind Pflichtfelder.

 

 
 

E-Plate CardioECR 48

The E-Plate® CardioECR 48 features two types of recording electrodes in each well. An innovative interdigitated microelectrode configuration enables real-time measurement of impedance, providing sensitive and real-time detection of cell viability and contractile activities. The additional point electrodes allow for extracellular field potential measurements, which can be performed in tandem with impedance recording. The footprint of the E-Plate complies with ANSI/SBS 1-2004 requirements, and the spacing of the wells in column is 9 mm center-to-center as per the ANSI/SBS 4-2004 standard for 96-well microplates.

For single use only.

6 Pieces

 

Weiterführende Links zu "E-Plate CardioECR 48"

Weitere Artikel von ACEA Biosciences Inc.
 

Hersteller-Beschreibung "ACEA Biosciences Inc."

ACEA Biosciences’ mission is to provide innovative high performance technologies that advance scientific discovery and improve healthcare.

Founded in 2002, ACEA Biosciences, Inc. is a privately owned biotechnology company that is pioneering the development and commercialization of high performance, cutting edge cell analysis instruments for life science research and clinical diagnostics.

Employing noninvasive impedance microelectrodes in automated high-throughput plate formats, our xCELLigence® Real-Time Cell Analysis (RTCA) instruments maximize the physiological relevance of data extracted from in vitro cellular assays. These instruments enable label-free, real-time monitoring of cell proliferation, cell size/morphology, cell-substrate attachment quality, and cell invasion/migration. By eliminating the time- and labor-intensive steps of traditional methods, RTCA vastly improves efficiency and overall productivity. Moreover, the flexibility, sensitivity, and reproducibility of RTCA make it a standout amongst cell-based assay platforms.

ACEA is also helping to revolutionize the field of flow cytometry by designing and producing high performance, customizable benchtop cytometers at accessible price points. By including features such as 13 fluorescence detection channels with 3 lasers, direct volumetric based cell counting, and a versatile high throughput walkaway autosampler, ACEA’s line of NovoCyte® flow cytometers is raising the bar for what is expected of benchtop machines.

 
Ihr Ansprechpartner
E-Mail: josef.freund@ols-bio.de
T +49 421 276 16 9-0
M +49 160 989 33 113
Systemkomponenten

E-Plate 48 CardioECR